Chase Investment Counsel Corp Stryker Corp Transaction History

Chase Investment Counsel Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$194.09 - $276.37 $2 Million - $2.85 Million	-10,322 Closed	0 $0
Q1 2022 Apr 21, 2022	BUY	$245.33 - $277.77 $2,943 - $3,333	12 Added 0.12%	10,322 $2.76 Million
Q4 2021 Feb 02, 2022	SELL	$236.63 - $276.44 $1.42 Million - $1.66 Million	-5,992 Reduced 36.76%	10,310 $2.76 Million
Q3 2021 Nov 04, 2021	SELL	$248.9 - $280.09 $219,032 - $246,479	-880 Reduced 5.12%	16,302 $4.3 Million
Q2 2021 Jul 29, 2021	BUY	$242.95 - $267.0 $1.36 Million - $1.49 Million	5,599 Added 48.34%	17,182 $4.46 Million
Q1 2021 May 06, 2021	BUY	$221.01 - $248.82 $25,416 - $28,614	115 Added 1.0%	11,583 $2.82 Million
Q4 2020 Feb 02, 2021	BUY	$202.01 - $245.04 $17,978 - $21,808	89 Added 0.78%	11,468 $2.81 Million
Q3 2020 Nov 03, 2020	BUY	$177.77 - $215.81 $2.02 Million - $2.46 Million	11,379 New	11,379 $2.37 Million

2,231

284M

1.35M

1.6M

Ticker SYK
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 378,320,992
Market Cap $138B
Description
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products c...

Get notified when there are updates to the investment portfolio of Chase Investment Counsel Corp, based on Form 13F filings with the SEC.

Stay updated on Chase Investment Counsel Corp with notifications on news.